AG
Artal Group’s TG Therapeutics TGTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-511,389
| Closed | -$7.69M | – | 126 |
|
2023
Q1 | $7.69M | Buy |
+511,389
| New | +$7.69M | 0.46% | 48 |
|
2022
Q2 | – | Sell |
-800,000
| Closed | -$7.61M | – | 140 |
|
2022
Q1 | $7.61M | Hold |
800,000
| – | – | 0.32% | 60 |
|
2021
Q4 | $15.2M | Hold |
800,000
| – | – | 0.41% | 48 |
|
2021
Q3 | $26.6M | Hold |
800,000
| – | – | 0.6% | 36 |
|
2021
Q2 | $31M | Sell |
800,000
-700,000
| -47% | -$27.2M | 0.63% | 30 |
|
2021
Q1 | $72.3M | Hold |
1,500,000
| – | – | 1.28% | 16 |
|
2020
Q4 | $78M | Hold |
1,500,000
| – | – | 1.68% | 16 |
|
2020
Q3 | $40.1M | Sell |
1,500,000
-250,000
| -14% | -$6.69M | 0.97% | 21 |
|
2020
Q2 | $34.1M | Buy |
1,750,000
+750,000
| +75% | +$14.6M | 0.95% | 24 |
|
2020
Q1 | $9.84M | Buy |
1,000,000
+350,000
| +54% | +$3.44M | 0.42% | 41 |
|
2019
Q4 | $7.22M | Sell |
650,000
-250,000
| -28% | -$2.78M | 0.28% | 50 |
|
2019
Q3 | $5.05M | Hold |
900,000
| – | – | 0.2% | 62 |
|
2019
Q2 | $7.79M | Buy |
900,000
+100,000
| +13% | +$865K | 0.31% | 53 |
|
2019
Q1 | $6.43M | Buy |
800,000
+400,000
| +100% | +$3.22M | 0.26% | 53 |
|
2018
Q4 | $1.64M | Hold |
400,000
| – | – | 0.06% | 71 |
|
2018
Q3 | $2.24M | Hold |
400,000
| – | – | 0.06% | 77 |
|
2018
Q2 | $5.26M | Buy |
400,000
+150,000
| +60% | +$1.97M | 0.11% | 46 |
|
2018
Q1 | $3.55M | Sell |
250,000
-150,000
| -38% | -$2.13M | 0.04% | 56 |
|
2017
Q4 | $3.28M | Hold |
400,000
| – | – | 0.05% | 47 |
|
2017
Q3 | $4.74M | Sell |
400,000
-100,000
| -20% | -$1.19M | 0.08% | 36 |
|
2017
Q2 | $5.03M | Buy |
+500,000
| New | +$5.03M | 0.09% | 40 |
|